Brachytherapy Boost for Gleason (GS) 7 Intermediate-Risk Prostate Adenocarcinoma Yields Excellent Biochemical Control and May Eliminate Therapeutic Benefit of Hormonal Therapy

Shasha, D ; Nabhani, T ; Mourad, W.F ; Patel, S ; Lukens, J.N ; Gámez, M ; Katsoulakis, E ; Patel, R ; Concert, C ; Ryniak, M ; Shourbaji, R.A ; Shah, N ; Santoro, J ; Ambrose, R ; Dolan, J ; Woode, R ; Goluboff, E ; Dinlenc, C ; Salant, R.L ; Harrison, L.B

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S427-S428 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível